
Pantavik IV 40mg Injection
Marketer
Elder Pharmaceuticals Ltd
Salt Composition
Pantoprazole (40mg)
Overview Pantavik IV 40mg Injection
Intravenous Pantavik (40mg) is a medication that suppresses gastric acid production. It's indicated for various acid-related gastrointestinal disorders, including acid reflux, peptic ulcers, and Zollinger-Ellison syndrome, offering both symptomatic relief and facilitating healing. Pre-operative administration helps prevent aspiration complications in critically ill patients, and it also mitigates stress ulcers. Classified as a proton pump inhibitor (PPI), this injectable formulation is administered intravenously by a healthcare professional only when deemed clinically superior to oral administration. Dosage and treatment duration are determined by your physician based on individual needs and response. Optimal results are often achieved by adopting dietary modifications such as consuming smaller, more frequent meals and avoiding caffeinated beverages, spicy, and high-fat foods. Commonly reported mild side effects include nausea, vomiting, headache, dizziness, flatulence, diarrhea, abdominal pain, and thrombophlebitis. Persistent or bothersome side effects warrant medical consultation. Prolonged use, especially exceeding one year or at higher doses, may increase the risk of bone fractures. Discuss bone health strategies, such as calcium and vitamin D supplementation, with your doctor. Prior to initiating treatment, inform your physician of any pre-existing conditions such as severe hepatic impairment, concurrent HIV medication use, prior allergic reactions to similar medications, or osteoporosis. Consult your doctor before use during pregnancy or breastfeeding. Alcohol consumption should be avoided due to its acid-stimulating effects. Refrain from operating machinery or driving if experiencing dizziness or drowsiness.
Primary Ingredients of Pantavik IV 40mg Injection
No information provided. Please provide the text you wish to be rewritten.
Uses of Pantavik IV 40mg Injection
Managing gastroesophageal reflux, peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Pantavik IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Pantavik IV 40mg Injection:
- Diarrhea
- Flatulence
- Headache
- Joint pain
- Nausea
- Stomach pain
- Vomiting
- Dizziness
- Thrombophlebitis
How to use Pantavik IV 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Pantavik IV 40mg Injection works:
Gastric acid production is decreased by the proton pump inhibitor Pantavik IV 40mg Injection, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Pantavik IV 40mg Injection is contraindicated.
PregnancyCONSULT YOUR DOCTOR
Administering Pantavik IV 40mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible hazards prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Pantavik IV 40mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Pantavik IV 40mg Injection on driving ability is unknown. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Pantavik IV 40mg Injection presents no need for dosage modification in individuals with renal impairment and is considered safe for their use.
LiverCAUTION
For individuals with severe hepatic impairment, administering Pantavik IV 40mg Injection requires careful consideration. Dosage modification of Pantavik IV 40mg Injection might be necessary. Physician consultation is advised.
What if you forget to take Pantavik IV 40mg Injection :
Omit a scheduled Pantavik IV 40mg Injection? Seek your physician's advice.
Facts to Know About Pantavik IV 40mg Injection
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Action Class | Gastric acid suppressants |
